Impact of muscle volume changes following atezolizumab‐bevacizumab therapy in patients with unresectable hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2025 at "Hepatology Research"
DOI: 10.1111/hepr.14201
Abstract: This study aimed to evaluate the prognostic impact of muscle volume changes during atezolizumab‐bevacizumab (AB) combination therapy (AB therapy) for unresectable hepatocellular carcinoma (u‐HCC). Additionally, we evaluated whether changes in muscle volume relate to prognosis… read more here.
Keywords: volume changes; therapy; impact muscle; muscle volume ... See more keywords